Loading clinical trials...
Loading clinical trials...
Neoadjuvant Chemoimmunotherapy Combined With Surgery Versus Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: a Multicenter Randomized Controlled Clinical Trial
Conditions
Interventions
Camrelizumab
Cisplatin
+4 more
Locations
12
China
Anhui Provincial Cancer Hospital
Hefei, Anhui, China
Beiing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
The First Affiliated Hospital (Southwest Hospital), Army Medical University (Third Military Medical University)
Chongqing, Chongqing Municipality, China
Gansu Provincial Maternity and Child-care Hospital
Lanzhou, Gansu, China
The Affiliated Tumor Hospital of Guangxi Medical University
Nanning, Guangxi, China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Start Date
April 22, 2024
Primary Completion Date
March 1, 2031
Completion Date
March 1, 2031
Last Updated
October 30, 2024
NCT06157151
NCT04895709
NCT07276360
NCT05283330
NCT04977453
NCT06349642
Lead Sponsor
Tongji Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions